Anton M. Bennett, PhD

Associate Professor of Pharmacology and of Comparative Medicine; Co-Director, Program in Integrative Cell Signaling and Neurobiology of Metabolism; Director, BBS Minority Affairs


Departments & Organizations

Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology

Stem Cell Center, Yale

Signal Transduction

Vascular Biology and Therapeutics Program

Comparative Medicine: Integrative Cell Signaling & Neurobiology of Metabolism (ICSNM)

Pharmacology: Neuropharmacology(

Liver Center)

Diabetes Endocrinology Research Center

Yale Core Center for Musculoskeletal Disorders

Signal Transduction

Research Interests

Signal transduction; Protein tyrosine phosphatases; Cancer; Diabetes; Obesity; Muscle stem cells; Muscular dystrophy


Education

  • Ph.D., New York Medical College, 1993

Selected Publication

  • Roth Flach, R.J., Zhang, and Bennett, A.M. (2011) Loss of MAP Kinase Phosphatase-1 protects from hepatic steatosis by repression of CIDEC/Fat-specific protein 27, J. Biol. Chem., 286: 22195-22202.

Latest Honor and Recognition

  • Burroughs-Wellcome Award for New Investigators in Pharmacology (2001)